Clinical Trial Update: Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and immunogenicity of an H1N1 influenza vaccine in adults with HIV infection. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• H1N1 influenza vaccine (Influenza A/H1N1 vaccine)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: HIV Infection | Phase 2 | Status: COMPLETED